Showing 478 news articles about New & experimental hepatitis C treatment

Filters Content type: Editors' picks Topic: New & experimental hepatitis C treatment

News and information about clinical trials and regulatory approval of new medications to treat hepatitis C.

New & experimental hepatitis C treatment

'Sponge' Drug Shows Promise For Treating Hepatitis C

Editor's pick
NPR (blog)
28 March 2013
New & experimental hepatitis C treatment

Gilead Announces Update on Phase 3 Study of Oral Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients

Editor's pick
Gilead press release
26 March 2013
New & experimental hepatitis C treatment

Presidio Pharmaceuticals Announces Collaboration with Boehringer Ingelheim

Editor's pick
Presidio press release
13 March 2013
Pharmaceutical industry

Pfizer stops developing hepatitis C drug

Editor's pick
EATG
10 March 2013
Pharmaceutical industry

Copy of Pfizer stops developing hepatitis C drug

Editor's pick
GMI Partnership
10 March 2013
New & experimental hepatitis C treatment

Four in Five People With HIV and Hep C on Faldaprevir Achieve Early Treatment Success

Editor's pick
AIDSMeds
7 March 2013
New & experimental hepatitis C treatment

Copy of Four in Five People With HIV and Hep C on Faldaprevir Achieve Early Treatment Success

Editor's pick
Kaiser Daily Global Health Policy Report
7 March 2013
Access to healthcare

UNITAID can address HCV/HIV co-infection

Editor's pick
The Lancet
23 February 2013
New & experimental hepatitis C treatment

Regulators Await Gilead's Hep C Candidate

Editor's pick
Seeking Alpha
22 February 2013
New & experimental hepatitis C treatment

Study may help design better DAA drug cocktails to treat HCV

Editor's pick
News Medical
20 February 2013
New & experimental hepatitis C treatment

Gilead's Sofosbuvir for Hepatitis C Meets Primary Endpoint in Fourth Pivotal Phase 3 Study

Editor's pick
Gilead press release
19 February 2013
New & experimental hepatitis C treatment

HCV polymerase inhibitor mericitabine boosts interferon/ribavirin cure rate

Editor's pick
HIVandHepatitis.com
13 February 2013
New & experimental hepatitis C treatment

Copy of HCV polymerase inhibitor mericitabine boosts interferon/ribavirin cure rate

Editor's pick
HIVandHepatitis.com
13 February 2013
New & experimental hepatitis C treatment

FISSION Study Should Support Regulatory Approval For Gilead's Hepatitis C Drug

Editor's pick
Seeking Alpha
7 February 2013
New & experimental hepatitis C treatment

Idenix to Discontinue Development of Two Hepatitis C Treatments

Editor's pick
Idenix press release
5 February 2013
New & experimental hepatitis C treatment

Gilead Announces Sustained Virologic Response Rates from Two Phase 3 Studies of Sofosbuvir for Hepatitis C

Editor's pick
Gilead press release
4 February 2013
Pharmaceutical industry

Vertex hepatitis C drug revenues plummet

Editor's pick
Boston Business Journal (blog)
30 January 2013
New & experimental hepatitis C treatment

Hepatitis C progress in pipeline: New drugs to treat virus expected be available in 2014-15

Editor's pick
Chicago Tribune
29 January 2013
New & experimental hepatitis C treatment

Phase II all-oral combination studies of simeprevir, TMC647055 and IDX719 for the treatment of hepatitis C to be initiated shortly

Editor's pick
Medivir press release
29 January 2013
New & experimental hepatitis C treatment

Guide to Clinical Trials for People with Hepatitis C

Editor's pick
Treatment Action Group
18 January 2013
New & experimental hepatitis C treatment

Achillion Continues To Make Significant Strides In The Fight Against Hepatitis C

Editor's pick
Seeking Alpha
15 January 2013
New & experimental hepatitis C treatment

Roche Scientists Uncover Unexpected Enzyme Activity in HCV RNA Polymerase

Editor's pick
Biospace
11 January 2013
New & experimental hepatitis C treatment

Nucleotide Polymerase Inhibitors - The Search For A Safe Interferon Free Trial

Editor's pick
HCV New Drugs Research
10 January 2013
New & experimental hepatitis C treatment

Idenix May Drop Delayed Hepatitis C Drug for New Versions

Editor's pick
Businessweek
10 January 2013